Farkas J C, Liu N, Bleriot J P, Chevret S, Goldstein F W, Carlet J
Service de Réanimation Polyvalente, Hôpital Saint Joseph, Paris, France.
Am J Med. 1992 Sep;93(3):277-82. doi: 10.1016/0002-9343(92)90233-2.
A prospective randomized study was conducted over a 23-month period in an adult medical-surgical intensive care unit to determine whether triple-lumen catheters reduce the need for peripheral vascular access and whether they are associated with a higher rate of infection than single-lumen catheters.
After the insertion route, internal jugular or subclavian, was selected by the physician, patients were randomized either to single-lumen or triple-lumen catheter groups. Complementary peripheral vascular access was allowed in both groups. Catheters were removed according to preestablished defined reasons: suspicion of catheter-related sepsis, uselessness of central venous access, duration of catheterization of more than 21 days, discharge from the intensive care unit, or death.
Data on 129 central venous catheters were collected from 91 consecutive patients. Twenty-five of 68 patients from the single-lumen group and 1 of 61 patients from the triple-lumen group needed peripheral vascular access (p less than 0.001). Catheter-related sepsis rates, defined either by clinical signs and positive qualitative tip cultures (8.9% versus 11.5%) or by quantitative tip cultures (16.2% versus 11.5%), were identical in the single-lumen and triple-lumen groups (type II error: 8%).
In intensive care units, the use of triple-lumen catheters is associated with a dramatic decrease in the need for peripheral vascular access. The incidence of central venous catheter-related sepsis appears identical for single- and triple-lumen catheters.
在一个成人内科-外科重症监护病房进行了一项为期23个月的前瞻性随机研究,以确定三腔导管是否能减少外周血管通路的需求,以及它们与单腔导管相比是否具有更高的感染率。
医生选定颈内静脉或锁骨下静脉作为置管途径后,将患者随机分为单腔导管组或三腔导管组。两组均允许使用辅助外周血管通路。根据预先确定的明确原因拔除导管:怀疑导管相关败血症、中心静脉通路无用、置管时间超过21天、从重症监护病房出院或死亡。
从91例连续患者中收集了129根中心静脉导管的数据。单腔导管组68例患者中有25例需要外周血管通路,三腔导管组61例患者中有1例需要外周血管通路(p<0.001)。单腔导管组和三腔导管组的导管相关败血症发生率相同,无论是根据临床体征和定性尖端培养阳性(8.9%对11.5%)还是定量尖端培养(16.2%对11.5%)来定义(II类错误:8%)。
在重症监护病房,使用三腔导管可显著减少外周血管通路的需求。单腔导管和三腔导管的中心静脉导管相关败血症发生率似乎相同。